Efficacy and Safety of Oral Dofetilide in Converting to and Maintaining Sinus Rhythm in Patients With Chronic Atrial Fibrillation or Atrial Flutter

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT

  2005cited by this paper
• Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.

  1999cited by this paper
• Drug treatment of atrial fibrillation in the managed care era.

  1998cited by this paper
• Rhythm Management in Atrial Fibrillation—With a Primary Emphasis on Pharmacological Therapy: Part 1

  1998cited by this paper
• Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.

  1997cited by this paper
• Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias.

  1996cited by this paper
• Pharmacokinetic and pharmacodynamic modeling of the effects of oral and intravenous administrations of dofetilide on ventricular repolarization

  1995cited by this paper
• Managing Chronic Atrial Fibrillation: A Markov Decision Analysis Comparing Warfarin, Quinidine, and Low-Dose Amiodarone

  1994cited by this paper
• Pharmacodynamics and Pharmacokinetics of the Class III Antiarrhythmic Agent Dofetilide (UK‐68,798) in Humans

  1993cited by this paper
• Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.

  1992cited by this paper
• Voltage- and time-dependent block of the delayed K+ current in cardiac myocytes by dofetilide.

  1992cited by this paper
• Clinical and electrophysiologic effects of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with angina pectoris.

  1992cited by this paper
• Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

  1990cited by this paper

• Dofetilide for the treatment of premature ventricular complexes and ventricular tachycardia in patients with structural heart disease

  2024cites this paper
• Chapter 1 Atrial Flutter — Diagnosis , Management and Treatment

  2018cites this paper
• Impact of a Pharmacy-Cardiology Collaborative Practice on Dofetilide Safety Monitoring

  2017cites this paper
• Short‐ and long‐term clinical predictors of pharmacological cardioversion of persistent atrial fibrillation by dofetilide: A retrospective cohort study of 160 patients

  2017cites this paper
• Estudio a largo plazo de la calidad de vida y remodelado estructural en pacientes en los que se realiza ablación mediante radiofrecuencia del flutter auricular típico

  2013cites this paper
• Contemporary Approach to Electrical and Pharmacological Cardioversion of Atrial Fibrillation

  2012cites this paper
• Strategies for the management of postoperative atrial fibrillation.

  2011cites this paper
• in Cardiovascular Medicine Drug-Induced Arrhythmia

  2010cites this paper
• Delayed adaptation of ventricular repolarization after sudden changes in heart rate due to conversion of atrial fibrillation. A potential risk factor for proarrhythmia?

  2005cites this paper
• Evaluation of KCB-328, a new IKr blocking antiarrhythmic agent in pacing induced canine atrial fibrillation.

  2004cites this paper